Sensitivity analysis of ICER estimates for QALYs gained in community-based therapy of <i>S. haematobium</i>.

<p>Shown are the 11 most influential inputs to the model and the effects of their variation on $US cost per lifetime QALY gained when calculating the incremental cost effectiveness of single-dose <i>vs.</i> double-dose treatment regimens in community-based programs. The base case analysis from <a href="" target="_blank">Table 4</a> is indicated by the vertical dotted line.</p>